Fetal Monitoring Market – By Product, By Portability, By Method, By End Use – Global Forecast 2025 – 2034

Fetal Monitoring Market Size

The global fetal monitoring market was estimated at USD 5.8 billion in 2024. The market is expected to grow from USD 6.1 billion in 2024 to USD 11.1 billion in 2034, at a CAGR of 6.8% during the forecast period.  
 

Fetal monitoring devices are used to track the vital signs and as well as the health status of the developing fetus during the pregnancy. This device encompasses continuous and periodic monitoring of the various parameters such as fetal heart rate, uterine contraction, among others to ensure the fetal well-being and to detect the potential issues associated with fetal growth.
 

The growth of the market is highly attributed due to the rising prevalence of pregnancy associated complications, such as placental abnormalities, preeclampsia, gestational diabetes, among others. For instance, as per the data from the Centers for Disease control and prevention (CDC), the rate of gestational diabetes among the pregnant women had increased form 6% in 2016 to 8.3% in 2021.
 

Additionally, according to the World Health organization (WHO), in 2020, around 287,000 women lost their lives due to complications associated with the pregnancy and the childbirth. Therefore, owing to growing prevalence of these pregnancy related complication, the demand for effective and advanced fetal monitoring devices is fostering, thereby contribution to the growth of the market.
 

Moreover, the growing inclination among the healthcare provider and the pregnant women towards the non-invasive fetal monitoring solution, fostering the market expansion. Non-invasive technologies such as the wearable monitoring devices and doppler ultrasound, which is estimated to reach USD 4 billion by 2032, offers enhanced precision and less discomfort for the pregnant women, bypassing the risk associated with the invasive procedures such as amniocentesis.
 

For instance, according to the study published in the National Library of Medicine, approximately 17% of women those undergone amniocentesis experienced preterm labor. Thus, the complications associated with the invasive procedures continuous to rise so does the need for safer and reliable non-invasive solution such as the fetal monitoring devices.
 

Fetal Monitoring Market Trends

• Ongoing technological innovations in the fetal monitoring devices, enhanced the effectiveness, accuracy and convenience of these devices, accelerating the market growth. Advancements such as remote and wireless monitoring, real time tracking as improved early detection of the fetal abnormalities, allowing for timely medical intervention.
   
• For instance, Novii+ Wireless Patch system of GE HealthCare is a non-invasive fetal and maternal monitoring system which is used during both intrapartum as well as in antepartum period. This system delivery the real time data pertaining to fetal heart rate, uterine activity, and maternal heart rate. Such innovations help the healthcare professional to make more informed decision, stimulating the adoption of these devices, further fueling the market growth.
   
• The rising prevalence of preterm births have accelerated the need for advance fetal monitoring devices. For instance, as per the data from the World Health Organization, approximately 13.4 million babies were born preterm in 2020.
   
• Preterm births often necessities continuous monitoring of the fetal health in order to the detect the abnormalities early, ensuring for timely medical intervention.
   

Fetal Monitoring Market Analysis

Based on product, the fetal monitoring market is segmented into ultrasound devices, electronic fetal monitoring (EFM), uterine contraction monitor, accessories and consumables, and other products. The ultrasound devices segment is further bifurcated into 2D ultrasound, 3D and 4D ultrasound, and doppler imaging. Furthermore, the electronic fetal monitoring (EFM) segment is further bifurcated into external EFM and internal EFM. The global fetal monitoring devices market was estimated at USD 5.8 billion in 2024. The ultrasound devices segment held revenues of USD 3 billion in the year 2024 and the segment is poised for significant growth at a CAGR of 6.9% during the forecast period.
 

• The increasing inclination towards the non-invasive procedure is a key catalyst for the dominance and adoption of ultrasound devices segment. This device provides a non-invasive alternative to monitor the fetal health without causing any harm and discomfort to the fetus and the mother.
   
• Moreover, technological innovations in the ultrasound imaging such as the upgradation from 2D to advanced 3D and 4D ultrasound imaging has significantly improved the fetal imaging, offering real time tracking of the fetal health and increasing the ability to the detect the abnormalities as early as possible.
   
• For instance, GE HealthCare’s Voluson S8 ultrasound is capable of capturing both 3D and 4D imaging. This device uses HDlive technologies, which is an advanced skin illuminating and shadow technology that provides in depth and clear visualization of the fetal structures.
   
• Such technological innovations stimulating the adoption of these devices by the healthcare providers for better patient outcomes, further fostering the growth of the segment in the fasting pacing market of fetal monitoring.
   

Based on portability, the fetal monitoring market is segmented into portable and non-portable. The portable segment held a market share of 37.9% in 2024 and the market is predicted to grow at 6.9% CAGR during the forecast period.
 

• The ease of use and movement offered by portable fetal monitoring devices makes it possible for healthcare providers to assess the patients at their homes or outpatient clinics. This flexibility stimulating the patient’s accessibility by decreasing the need for frequent visit to the healthcare facilities, making prenatal care more effective and convenient among the patients especially prone to pregnancy related complication.
   
• Moreover, the fetal monitoring devices encompass remote monitoring feature, which allows the healthcare provider to monitor the fetus health over long distance. This feature predominantly accelerated the growth of the segment in the period of COVID-19.
   
• Additionally, these devices can also be integrated into healthcare services at a lower cost, and as technology continues to advance, the efficiency and usability of these devices will improve, further enabling the segment to maintain their market dominance in fetal monitoring.
   

Based on method, the fetal monitoring market is segmented into invasive and non-invasive. The non-invasive segment dominated the market and accounted for about 76% market share in the year 2024 and is anticipated to witness the highest growth during the forecast period.
 

• The dominance of the segment is highly owing to the advancement offered by the non-invasive fetal monitoring devices over the invasive devices.
   
• Non-invasive devices such as ultrasound poses less risk to the mother and the fetus, these devices significantly reduce penetration into the mother’s body which in turn decreases the chance of bleeding, infection and other complications.
   
• Moreover, technological advancement in the non-invasive devices such as the doppler fetal monitoring system, cableless fetal monitoring system and wearable monitoring system have made this product more accurate, convenient and portable, fostering these devices adoption among the healthcare providers.
   
• A notable example is Philips Avalon CL cableless maternal and fetal monitoring system, which emphasizes the advantage offered by non-invasive devices. This device significantly reduces the cable clutter in OB department, allowing the mother to move around freely during the labor.
   
• Moreover, this device monitor’s the fetal heart rate, SpO2 without any incision on the mother body, fostering the adoption of these devices among the patient and physicians due their non-invasive nature, stimulating the segment growth.
   

The fetal monitoring market by end user is categorized into hospitals, specialty clinics, and other end users. The hospital segment is estimated to grow substantially to reach over USD 5.9 billion revenue size by the end of 2034.
 

• Hospital is the primary point of care for prenatal checkup, delivery and labor services. Growing birth rate in several regions across the globe and expanding emphasis on fetal and maternal health stimulating the demand for advanced fetal monitoring system in the hospital setting.
   
• Moreover, the government as well as the private healthcare institutes invest heavily over the hospital infrastructure, digital healthcare, and various maternal care programs ruined in the hospitals.
   
• For instance, the Ministry of Health and Family Welfare (MoHFW) of India launched Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) across the public health facilities including hospitals in India, which provide free maternal care for the pregnant women on the 9th day of every month. The major aim of this program is to detect and monitor high risk pregnancy in order to provide timely medical intervention, which will in turn play a significant role in reducing the rate of maternal mortality rates (MMR) in India.  
   
• Therefore, such initiatives in the hospitals requires advanced fetal monitoring device in order to detect the abnormalities, further fostering the demand of these devices in the hospital settings.
   

In 2024, the U.S. led the North American market, generated a revenue of about USD 2 billion.
 

• This growth is highly attributed due to the rising prevalence of pregnancy associated complication across the country.
   
• For instance, according to the data from the Centers for Disease Control and Prevention (CDC), annually around 2% to 10% of the pregnant women in the U.S. are impacted by the gestational diabetes.
   
• Thus, the increasing prevalence of this condition among the pregnant women population across the country, accelerating the need for advance fetal monitoring devices in order to manage the potential risk and complication associated with the condition.
   

Europe: The fetal monitoring market in the UK is projected to grow significantly from 2025 to 2034.
 

• The rising rate of still birth and fetal related deaths in the country is a significant catalyst for the growth of the market in the country.
   
• According to the estimates in 2022, around 1 in every 250 pregnancies in the UK ended in stillbirth, which is equivalent to 8 stillbirth every day in that year.
   
• Thus, these alarming statistics necessities the need of effective and convenient fetal monitoring system in order to tackle the situation, thereby propelling the growth of the market in the country.
   

Asia Pacific: The fetal monitoring market in the Japan is projected to grow significantly from 2025 to 2034.
 

• Japan is forefront in the field of technological innovation, thus the ongoing development in the fetal monitoring technologies, such as remote monitoring and non-invasive devices are fuelling the market growth and the adoption of these devices among the healthcare providers in the country.
   
• Moreover, the Japanese government is promoting maternal and childcare health through various subsidies, policies, and as well as the public educating campaigns such as Healthy Parents & Children 21.
   
• These programs foster the awareness among the pregnant women across the country pertaining to the early detection and monitoring of the fetal growth and abnormalities, further propelling the adoption of the monitoring practice across the country, thereby accelerating the market growth.
   

Middle East and Africa: The fetal monitoring market in the Saudi Arabia is projected to grow significantly from 2025 to 2034.
 

• The countries high birth rate is a significant accelerator for the growth of the market in the country. According to the data from the World Bank the birth rate of the country was 16.92% per thousand people in 2022.
   
• This growing birth rate in the country fuelling the demand for advance fetal monitoring solution in order to ensure safer deliveries and pregnancy across the country.
   

Fetal Monitoring Market Share

The top 4 players of the market account for approximately 56% of the market share which includes companies such as Koninklijke Philips, Siemens Healthineers, Medtronic, FUJIFILM Holdings Corporation, among others. Moreover, strategic partnerships with maternity clinics, hospitals, healthcare providers, research institutes, and government agencies play a primary role in advancing the development of products and getting the necessary permits. The development of public awareness through the campaigns, social media platform is playing a crucial role in enhancing product development and expanding market reach, enabling market players to strengthen their position in this growing sector.
 

Fetal Monitoring Market Companies

Some of the eminent market participants operating in the fetal monitoring industry include:

• Becton, Dickinson and Company
• Biolight Medical
• Cardinal Health
• DOTO Health
• EDAN Instrument
• FUJIFILM Holdings Corporation
• GE Healthcare
• Huntleigh Healthcare (Arjo)
• Koninklijke Philips
• MedGyn products
• Medtronic
• Natus Medical
• Neoventa Medical
• Siemens Healthineers
• Spacelabs Healthcare
   
• Medtronic has a strong focus on R&D activities, the company has invested approximately USD 2,735 million in the financial year 2023-24.
   
• Koninklijke Philips has a strong financial position; the company had reported a total revenue of USD 19,039.8 million for the financial year 2023.
   

Fetal Monitoring Industry News:

• In February 2024, GE HealthCare announced that its Novii+ Wireless Patch Solution had received 510(k) clearance from the U.S. FDA. This non-invasive maternal and fetal monitoring system was designed for use during both antepartum and intrapartum periods, offering real-time tracking of fetal heart rate, maternal heart rate, and uterine activity. By enabling care teams to monitor critical patient data in real-time, this approval strengthened GE HealthCare’s competitive position in the market.
   
• In June 2023, Neoventa Medical partnered with YMS, a distributor and reseller of various medical supplies, to offer advanced fetal monitoring solutions tailored to the unique needs of healthcare providers in South Africa. Such partnerships and collaborations augment industry expansion.
   

The fetal monitoring market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Ultrasound devices
  • 2D ultrasound
  • 3D and 4D ultrasound
  • Doppler imaging 
• Electronic fetal monitoring (EFM)
  • External EFM
  • Internal EFM
• Uterine contraction monitor
• Accessories and consumables
• Other products

Market, By Portability

• Portable
• Non-portable

Market, By Method

• Invasive
• Non-invasive

Market, By End User

• Hospitals
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE